Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6533)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2014 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Akhtar R, Chandel S, Sarotra P, Medhi B. Current status of pharmacological treatment of colorectal cancer. World J Gastrointest Oncol 2014; 6(6): 177-183 [PMID: 24936228 DOI: 10.4251/wjgo.v6.i6.177] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v6/i6/177.htm |
| Number | Citing Articles |
| 1 |
Dibyashree Chhetri, Ilango Kaliappan, Kanagaraj Palaniyandi, Dhanavathy Gnanasampanthapandian. Handbook of Oncobiology: From Basic to Clinical Sciences. 2023; : 1 doi: 10.1007/978-981-99-2196-6_48-1
|
| 2 |
T.-W. Chien, Y. Chang, K.-S. Wen, Y.-H. Uen. Using graphical representations to enhance the quality-of-care for colorectal cancer patients. European Journal of Cancer Care 2018; 27(1): e12591 doi: 10.1111/ecc.12591
|
| 3 |
Jia-Yi Wang, Yu-Hao Lu, Fang Li, Mo-Li Huang. Pyroptosis: A promising biomarker for predicting colorectal cancer prognosis and enhancing immunotherapy efficacy. World Journal of Clinical Oncology 2024; 15(8): 968-974 doi: 10.5306/wjco.v15.i8.968
|
| 4 |
Serra Gülse Köse, Aliye Ezgi Güleç Taşkıran. Mechanisms of drug resistance in nutrient-depleted colorectal cancer cells: insights into lysosomal and mitochondrial drug sequestration. Biology Open 2024; 13(10) doi: 10.1242/bio.060448
|
| 5 |
Ragna M.S. Haegebaert, Maxime Kempers, Wim Ceelen, Ine Lentacker, Katrien Remaut. Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer. European Journal of Pharmaceutics and Biopharmaceutics 2022; 172: 16 doi: 10.1016/j.ejpb.2022.01.002
|
| 6 |
Sarah Theiner, Christoph Kornauth, Hristo P Varbanov, Mathea S Galanski, Sushilla Van Schoonhoven, Petra Heffeter, Walter Berger, Alexander E Egger, Bernhard K Keppler. Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(iv)-based anticancer agents. Metallomics 2015; 7(8): 1256 doi: 10.1039/c5mt00028a
|
| 7 |
Bashir A. Yousef, Hozeifa M. Hassan, Muhanad Elhafiz, Luyong Zhang, Zhenzhou Jiang. Synergistic anti-cancer effect of pristimerin and docetaxel on human colorectal HCT-116 cells. Synergy 2020; 11: 100068 doi: 10.1016/j.synres.2020.100068
|
| 8 |
Belayneh Kefale, Melaku Tadege Engidaw, Desalegn Tesfa, Mulugeta Molla, Yitayih Kefale, Chernet Tafere. Management pattern and medication-related harms and its predictors in colorectal cancer patients: an institutional-based retrospective study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1253845
|
| 9 |
Wentian Wang, Lu Zhang, Lorraine Morlock, Noelle S. Williams, Jerry W. Shay, Jef K. De Brabander. Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC). Journal of Medicinal Chemistry 2019; 62(10): 5217 doi: 10.1021/acs.jmedchem.9b00532
|
| 10 |
Rosane Borges Dias, Ludmila de Faro Valverde, Clarissa Araújo Gurgel Rocha, Daniel Pereira Bezerra. Bioactive Essential Oils and Cancer. 2015; : 1 doi: 10.1007/978-3-319-19144-7_1
|
| 11 |
Hadar Goldvaser, Ofer Purim, Yulia Kundel, Daniel Shepshelovich, Tzippy Shochat, Lital Shemesh-Bar, Aaron Sulkes, Baruch Brenner. Colorectal cancer in young patients: is it a distinct clinical entity?. International Journal of Clinical Oncology 2016; 21(4): 684 doi: 10.1007/s10147-015-0935-z
|
| 12 |
Yimin Li, Yaqi Gan, Jiaxin Liu, Juanni Li, Zhengwei Zhou, Ruotong Tian, Ruizheng Sun, Jiaqi Liu, Qing Xiao, Yuanyuan Li, Pengyan Lu, Yulong Peng, Yuqian Peng, Guang Shu, Gang Yin. Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-00902-6
|
| 13 |
Valérie Vinette, Morgane Placet, Guillaume Arguin, Fernand-Pierre Gendron, Hendrik W. van Veen. Multidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5’-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic Drugs. PLOS ONE 2015; 10(8): e0136080 doi: 10.1371/journal.pone.0136080
|
| 14 |
Caiyan Wang, Xiaojun Teng, Chuang Wang, Binjie Liu, Runze Zhou, Xueyu Xu, Huawei Qiu, Yu Fu, Rongjin Sun, Zuhui Liang, Rong Zhang, Zhongqiu Liu, Lin Zhang, Lijun Zhu. Insight into the mechanism of Xiao–Chai–Hu–Tang alleviates irinotecan-induced diarrhea based on regulating the gut microbiota and inhibiting Gut β-GUS. Phytomedicine 2023; 120: 155040 doi: 10.1016/j.phymed.2023.155040
|
| 15 |
Achim Buck, Susanne Halbritter, Christoph Späth, Annette Feuchtinger, Michaela Aichler, Horst Zitzelsberger, Klaus-Peter Janssen, Axel Walch. Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSI. Analytical and Bioanalytical Chemistry 2015; 407(8): 2107 doi: 10.1007/s00216-014-8237-2
|
| 16 |
Lin Gan, Changjiang Yang, Long Zhao, Shan Wang, Zhidong Gao, Yingjiang Ye. Prognostic Biomarker SPOCD1 and Its Correlation with Immune Infiltrates in Colorectal Cancer. Biomolecules 2023; 13(2): 209 doi: 10.3390/biom13020209
|
| 17 |
Sumit Basu, Min Zeng, Taijun Yin, Song Gao, Ming Hu. Development and validation of an UPLC–MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats. Journal of Chromatography B 2016; : 34 doi: 10.1016/j.jchromb.2016.02.012
|
| 18 |
Luca Falzone, Letizia Scola, Antonino Zanghì, Antonio Biondi, Antonio Di Cataldo, Massimo Libra, Saverio Candido. Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development. Aging 2018; 10(5): 1000 doi: 10.18632/aging.101444
|
| 19 |
Samar Al Bitar, Farah Ballout, Alissar Monzer, Mariam Kanso, Nour Saheb, Deborah Mukherji, Walid Faraj, Ayman Tawil, Samer Doughan, Maher Hussein, Wassim Abou-Kheir, Hala Gali-Muhtasib. Thymoquinone Radiosensitizes Human Colorectal Cancer Cells in 2D and 3D Culture Models. Cancers 2022; 14(6): 1363 doi: 10.3390/cancers14061363
|
| 20 |
Lin Gan, Changjiang Yang, Long Zhao, Shan Wang, Yingjiang Ye, Zhidong Gao. The expression of ERAP1 is favorable for the prognosis and immunotherapy in colorectal cancer: a study based on the bioinformatic and immunohistochemical analysis. Clinical and Translational Oncology 2024; doi: 10.1007/s12094-024-03520-6
|
| 21 |
Al B. Benson, Igor Kiss, John Bridgewater, Ferry A.L.M. Eskens, Carolyn Sasse, Sandra Vossen, Jihong Chen, Chip Van Sant, Howard A. Ball, Anne Keating, Andrew Krivoshik. BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer. Clinical Cancer Research 2016; 22(20): 5058 doi: 10.1158/1078-0432.CCR-15-3117
|
| 22 |
Maria Rita Milone, Biagio Pucci, Tommaso Colangelo, Rita Lombardi, Federica Iannelli, Vittorio Colantuoni, Lina Sabatino, Alfredo Budillon. Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype. Molecular Oncology 2016; 10(8): 1344 doi: 10.1016/j.molonc.2016.07.006
|
| 23 |
Sekar Jinendiran, Hans-Uwe Dahms, B.S. Dileep Kumar, Vinoth Kumar Ponnusamy, Natesan Sivakumar. Diapolycopenedioic-acid-diglucosyl ester and keto-myxocoxanthin glucoside ester: Novel carotenoids derived from Exiguobacterium acetylicum S01 and evaluation of their anticancer and anti-inflammatory activities. Bioorganic Chemistry 2020; 103: 104149 doi: 10.1016/j.bioorg.2020.104149
|
| 24 |
Kyungeun Park, Youngeun Jeon, Joonwon Bae, Seongsoo Kim, Dong-Sik Shin. One-Pot Preparation of Alpha-Chymotrypsin Degradable Hydrogel Micropatterns for Controlled Drug Release. Korean Journal of Chemical Engineering 2024; 41(9): 2651 doi: 10.1007/s11814-024-00205-2
|
| 25 |
Rita Seeböck, Nicole Golob-Schwarzl, Stefanie Krassnig. Mechanisms of Molecular Carcinogenesis – Volume 1. 2017; : 77 doi: 10.1007/978-3-319-53659-0_5
|
| 26 |
Muhammed A. Bakhrebah, Mohammad Nasrullah, Wesam H. Abdulaal, Mohammed A. Hassan, Halima Siddiqui, Huda A. Al Doghaither, Ulfat M. Omar, Nawal Helmi, Mohannad M. Fallatah, Ayat B. Al-Ghafari, Mohammad Imran Khan, Hani Choudhry. High Expression of Pd-1 in Circulating Cells of Patients With Advanced Colorectal Cancer Receiving Adjuvant Therapy. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820969446
|
| 27 |
Jiaxin Liu, Yimin Li, Qing Xiao, Yuanyuan Li, Yuqian Peng, Yaqi Gan, Guang Shu, Hanxi Yi, Gang Yin. Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10126-0
|
| 28 |
Vinod K. Nelson, Mohana Vamsi Nuli, Juturu Mastanaiah, Mohamed Saleem T. S., Geetha Birudala, Yahya F. Jamous, Omar Alshargi, Kranthi Kumar Kotha, Hari Hara Sudhan, Ravishankar Ram Mani, Alagusundaram Muthumanickam, Divya Niranjan, Nem Kumar Jain, Ankur Agrawal, Arvind Singh Jadon, Vinyas Mayasa, Niraj Kumar Jha, Adriana Kolesarova, Petr Slama, Shubhadeep Roychoudhury. Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1201198
|
| 29 |
Xin Wang, Jian Wang, Jingjing Wu. Emerging roles for HMGA2 in colorectal cancer. Translational Oncology 2021; 14(1): 100894 doi: 10.1016/j.tranon.2020.100894
|
| 30 |
Sona Vodenkova, Tomas Buchler, Klara Cervena, Veronika Veskrnova, Pavel Vodicka, Veronika Vymetalkova. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacology & Therapeutics 2020; 206: 107447 doi: 10.1016/j.pharmthera.2019.107447
|
| 31 |
Mona S Abdellateif, Salem E Salem, Doaa M Badr, Sabry Shaarawy, Marwa M Hussein, Abdel-Rahman Zekri, Mariam A Fouad. The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients. Journal of Inflammation Research 2020; : 1245 doi: 10.2147/JIR.S283069
|
| 32 |
Julita Kulbacka, Kazimiera A. Wilk, Urszula Bazylińska, Magda Dubińska-Magiera, Stanisław Potoczek, Jolanta Saczko. Curcumin Loaded Nanocarriers with Varying Charges Augmented with Electroporation Designed for Colon Cancer Therapy. International Journal of Molecular Sciences 2022; 23(3): 1377 doi: 10.3390/ijms23031377
|
| 33 |
Dibyashree Chhetri, Ilango Kaliappan, Kanagaraj Palaniyandi, Dhanavathy Gnanasampanthapandian. Handbook of Oncobiology: From Basic to Clinical Sciences. 2024; : 995 doi: 10.1007/978-981-99-6263-1_48
|
| 34 |
Małgorzata Milczarek, Anna Pogorzelska, Katarzyna Wiktorska. Synergistic Interaction between 5-FU and an Analog of Sulforaphane—2-Oxohexyl Isothiocyanate—In an In Vitro Colon Cancer Model. Molecules 2021; 26(10): 3019 doi: 10.3390/molecules26103019
|